Aptose Biosciences (APS) has shared an announcement.
Aptose Biosciences Inc. has secured a $10 million loan from Hanmi Pharmaceutical Co., Ltd., repayable by January 31, 2027, with an option for early repayment without penalty and an annual interest rate of six percent. This loan can be converted into a prepayment for future milestone obligations if both parties amend their existing license agreement or establish a new collaboration agreement, effectively satisfying the loan under the original terms.
For an in-depth examination of APS stock, go to TipRanks’ Stock Analysis page.
